These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7534743)

  • 1. Autoimmunity, autoimmune diseases and lymphoproliferative disorders.
    Caligaris-Cappio F; Bertero MT; Bergui L
    Haematologica; 1994; 79(6):487-92. PubMed ID: 7534743
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice.
    Eisenberg RA; Sobel ES; Reap EA; Halpern MD; Cohen PL
    Semin Immunol; 1994 Feb; 6(1):49-54. PubMed ID: 8167307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP; Eisenberg RA; Cohen PL
    J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B cell self-tolerance by BAFF.
    Brink R
    Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell conducts the lymphocyte orchestra.
    Youinou P
    J Autoimmun; 2007; 28(2-3):143-51. PubMed ID: 17363215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell specific natural IgM autoantibodies: multifunctional regulators of the humoral immune response (a review).
    Uher F; Kiss K; Rácz J; Mihalik R; Puskás E; Alonso ME
    Acta Microbiol Immunol Hung; 1995; 42(1):3-17. PubMed ID: 7620810
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
    Rieux-Laucat F; Le Deist F; Fischer A
    Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal autoimmunity in hematology.
    Marmont AM; Merlini G
    Haematologica; 1991; 76(6):449-59. PubMed ID: 1840329
    [No Abstract]   [Full Text] [Related]  

  • 18. BAFF, APRIL and human B cell disorders.
    Tangye SG; Bryant VL; Cuss AK; Good KL
    Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of grafted gld cells in athymic and euthymic recipients.
    Rosenblatt N; Hartmann KU; Loor F
    Immunology; 1995 Apr; 84(4):562-70. PubMed ID: 7790030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.